| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Myasthenia Gravis
|
NINDS
|
5R01NS051833-03
|
|
Murine Models of Presynaptic Neuromuscular Disease
|
ATCHISON, WILLIAM
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$329,897
|
|
Myasthenia Gravis
|
NINDS
|
2R01NS042169-05A1
|
|
Mechanisms of Neurotransmitter-gated Ion Channels
|
GROSMAN, CLAUDIO
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$334,688
|
|
Myasthenia Gravis
|
NINDS
|
5R37NS023513-20
|
|
Multiple Activity Patterns of Acetylcholine Receptors
|
AUERBACH, ANTHONY
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$521,864
|
|
Myasthenia Gravis
|
NINDS
|
5R01NS052463-03
|
|
EAMG: MIR structure and specific immunosuppressive therapy
|
LINDSTROM, JON
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$434,391
|
|
Myasthenia Gravis
|
NINDS
|
5R01NS055028-02
|
|
Patterning and Formation of the Neuromuscular Junction
|
LIN, WEICHUN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$343,438
|
|
Myasthenia Gravis
|
NINDS
|
1F30NS061401-01
|
|
MicroRNAs and their Targets are Novel Regulators of NMJ Morphology in Drosophila
|
PENNEY, ELLEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$40,972
|
|
Myasthenia Gravis
|
NINDS
|
5R01NS006277-43
|
|
Congenital Myasthenic Syndromes
|
ENGEL, ANDREW
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$524,388
|
|
Myasthenia Gravis
|
NINDS
|
5R37NS019195-27
|
|
Extracellular Matrix and Neuromuscular Development
|
SANES, JOSHUA
|
HARVARD UNIVERSITY
|
MA
|
$532,351
|
|
Myasthenia Gravis
|
NIGMS
|
5R01GM076063-03
|
|
Alkoxypsoralens, Small Molecule Blockers of the Voltage-Gated Kv1.3 Channel
|
WULFF, HEIKE
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$255,640
|
|
Myasthenia Gravis
|
NIDCD
|
5R03DC007983-03
|
|
Molecular mechanisms of aging in the intrinsic laryngeal muscles
|
MCMULLEN, COLLEEN
|
UNIVERSITY OF KENTUCKY
|
KY
|
$71,126
|
|
Myasthenia Gravis
|
NIA
|
5R36AG029667-02
|
|
Effects of aging on immunity and autoimmunity
|
WILLIAMS, EARLANDA
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$51,183
|
|
Myasthenia Gravis
|
NINDS
|
5R01NS050388-04
|
|
In vivo studies of synapse formation in zebrafish
|
EPLEY, KIMBERLY
|
UNIVERSITY OF FLORIDA
|
FL
|
$223,324
|
|
Myasthenia Gravis
|
NINDS
|
1R01NS056415-01A2
|
|
Neuromuscular Junction Formation
|
MEI, LIN
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$294,000
|
|
Myasthenia Gravis
|
NINDS
|
5R01NS054154-03
|
|
Genetics of the Neuromuscular Junction: Mechanisms and Disease Models
|
BURGESS, ROBERT
|
JACKSON LABORATORY
|
ME
|
$367,038
|
|
Myasthenia Gravis
|
NINDS
|
5F30NS053013-02
|
|
Signaling Mechanisms Behind nAChR Clustering at the NMJ
|
LINNOILA, JENNY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$41,331
|
|
Myasthenia Gravis
|
NINDS
|
5U01NS042685-04
|
|
Thymectomy in Non-Thymomatous MG Patients on Prednisone
|
CUTTER, GARY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$916,666
|
|
Myasthenia Gravis
|
NINDS
|
5K08NS058800-02
|
|
Immunoregulation of Experimental Autoimmune Myasthenia Gravis
|
MERIGGIOLI, MATTHEW
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$177,196
|
|
Myasthenia Gravis
|
NINDS
|
5U01NS050733-04
|
|
Thymectomy in non-thymomatous MG patients on Prednisone
|
BUCKLEY, CAMILLA
|
UNIVERSITY OF OXFORD
|
UK
|
$1
|
|
Myasthenia Gravis
|
NINDS
|
1K99NS062738-01
|
|
How Ephexin Signaling Promotes Neuronal Stability
|
FRANK, CARL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$85,428
|
|
Myasthenia Gravis
|
NINDS
|
5R37NS018205-29
|
|
Regulation of Acetylcholine Receptors on Muscle
|
BREHM, PAUL
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$327,878
|
|
Myasthenia Gravis
|
NINDS
|
2R01NS036193-11
|
|
Signaling by MuSK, a component of the Agrin receptor
|
BURDEN, STEVEN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$401,375
|
|
Myasthenia Gravis
|
NINDS
|
5F32NS053258-03
|
|
Rapsyn regulation of ACh receptor function
|
VERDECIA, MARK
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$52,048
|
|
Myasthenia Gravis
|
NINDS
|
1R21NS061184-01A1
|
|
NEW APPROACHES TO THE MECHANISM AND THERAPY FOR MYASTHENIA GRAVIS
|
CHEN, JEANNIE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$175,854
|
|
Myasthenia Gravis
|
NINDS
|
1F31NS063519-01
|
|
A role for the miroRNA miR-133b in synapse development
|
HEYER, MARY
|
DUKE UNIVERSITY
|
NC
|
$30,045
|
|
Myasthenia Gravis
|
NIAID
|
5U19AI067152-04
|
0004
|
Common Variable Immune Deficiency, IgA Deficiency, Myasthenia Gravis Study
|
BEHRENS, TIMOTHY
|
UNIVERSITY OF MINNESOTA
|
MN
|
$261,163
|
|
Myasthenia Gravis
|
NINDS
|
5U19AI067152-04
|
0004
|
Common Variable Immune Deficiency, IgA Deficiency, Myasthenia Gravis Study
|
BEHRENS, TIMOTHY
|
UNIVERSITY OF MINNESOTA
|
MN
|
$19,408
|
|
Myasthenia Gravis
|
NIAID
|
5U19AI067152-04
|
0005
|
Common Variable Immune Deficiency, IgA Deficiency, Myasthenia Gravis Study
|
HAMMARSTROM, LENNART
|
KAROLINSKA INSTITUTE
|
SWEDEN
|
$134,694
|
|
Myasthenia Gravis
|
NINDS
|
5U19AI067152-04
|
0005
|
Common Variable Immune Deficiency, IgA Deficiency, Myasthenia Gravis Study
|
HAMMARSTROM, LENNART
|
KAROLINSKA INSTITUTE
|
SWEDEN
|
$10,010
|
|
Myasthenia Gravis
|
NINDS
|
3R01NS036193-11S1
|
|
Signaling by MuSK, a component of the Agrin receptor
|
BURDEN, STEVEN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$40,000
|
|
Myasthenia Gravis
|
NINDS
|
Y1NS6030-3-0-1
|
|
Myasthenia Gravis (MGTX) Phase III Clinical Trial
|
NO PI IDENTIFIED
|
|
|
$200,500
|
|
Myasthenia Gravis
|
NCRR
|
5M01RR000034-48
|
8775
|
CLINICAL TRIAL: THYMECTOMY TO NO THYMECTOMY IN NON -THYMOMATOUS MG PATIENTS
|
KISSEL, JOHN
|
OHIO STATE UNIVERSITY
|
OH
|
$346
|
|
Myasthenia Gravis
|
NCRR
|
5M01RR000109-44
|
5424
|
CLINICAL TRIAL: PILOT TRIAL OF RITUXIMAB IN REFRACTORY MYASTHENIA GRAVIS
|
TANDAN, RUP
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$8,244
|
|
Myasthenia Gravis
|
NIDCR
|
1Z01DE000724-01
|
|
Mechanisms of Pain and Immune Processes
|
IADAROLA, MICHAEL
|
NIH
|
|
$847,649
|
|
Myasthenia Gravis
|
NINDS
|
1Z01NS002974-10
|
|
Studies Of Hereditary Neurological Disease: Disease Gene Identification
|
FISCHBECK, KENNETH
|
NIH
|
|
$1,212,953
|
